The clinical dilemma of cardiac allograft vasculopathy - An introduction to the clinical session

Zeitschrift fur Kardiologie

Volumn 89, Issue SUPPL. 9, 2000, Pages

  Von Scheidt, W ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Cardiac allograft vasculopathy; Pathogenesis; Prognosis; Treatment

Indexed keywords

CARDIAC ALLOGRAFT VASCULOPATHY; CONFERENCE PAPER; DISEASE COURSE; ENDOTHELIUM INJURY; HEART TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; PATHOGENESIS; PREDICTION; PROGNOSIS; RISK; TREATMENT PLANNING; VASCULAR DISEASE;

ALGORITHMS; ANIMALS; AUTOPSY; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; CORONARY CIRCULATION; CORONARY VESSELS; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMANS; MICROCIRCULATION; PROGNOSIS; REGISTRIES; RISK; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TUNICA INTIMA; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 18844468349     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003920070026     Document Type: Conference Paper

References (55)

1. Cardiac allograft vasculopathy is abrogated by anti-CD8 monoclonal antibody therapy
2. Transplant tolerance: Will genes protect the graft?
3. Gene polymorphisms for plasminogen activator inhibitor-1/tissue plasminogen activator and development of allograft coronary artery disease
4. Intracoronary adenovirus-mediated transfer of immunosuppressive cytokine genes prolongs allograft survival
5. The role of inducible nitric oxide synthase in cardiac allograft rejection
6. Late blockade of T cell costimulation interrupts progression of experimental chronic allograft rejection
7. Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts
8. Heart transplant coronary artery disease detected by angiography: A multi-institutional study of preoperative donor and recipient risk factors. Cardiac transplant research database
9. Donor ACE gene polymorphism: A genetic risk factor for accelerated coronary sclerosis following cardiac transplantation
10. The clinical significance of antibodies to human vascular endothelial cells after cardiac transplantation
11. Accelerated coronary vascular disease in the heart transplant patient: Coronary arteriographic findings
12. Does rapidity of development of transplant coronary artery disease portend a worse prognosis?
13. Chronic blockade of CD28-B7-mediated T-cell costimulation by CTLA4Ig reduces intimal thickening in MHC class I and II incompatible mouse heart allografts
14. Treatment with rapamycin and mycophenolate acid reduces arterial intimal thickening produced by mechanical injury and allows endothelial replacement
15. Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes
16. Sirolimus (rapamycin) reverses the progression of graft vascular disease in primate aortic allografts
17. The spectrum of coronary artery pathologic findings in human cardiac allografts
18. Impact of intravascular ultrasound in understanding transplant coronary artery disease
19. Effects of pravastatin on outcome after cardiac transplantation
20. Immune sources of transforming growth factor-β1 reduce transplant arteriosclerosis: Insights derived from a knockout mouse model
21. NOS2 mediates opposing effects in models of acute and chronic cardiac rejection
22. Attenuated cardiac allograft vasculopathy in mice with targeted deletion of the transcription factor Stat4
23. Blockade of very late antigen-4 integrin binding to fibronectin in allograft recipients
24. Histopathology of orthotopic canine cardiac homografts
25. The use of CD4 and CD8 knockout mice to study the role of T-cell subsets in allotransplant rejection
26. Endothelial activation and development of coronary artery disease in transplanted human hearts
27. Estrogen effects on insulin-like growth factor-I (IGF-I)-induced cell proliferation and IGF-I expression in native and allograft vessels
28. Predictive model to assess risk for cardiac allograft vasculopathy: An intravascular ultrasound study
29. An intravascular ultrasound study of the influence of angiotensin-converting enzyme inhibitors and calcium entry blockers on the development of cardiac allograft vasculopathy
30. Different inhibitory effects of immunsuppressive drugs on human and rat aortic smooth muscle and endothelial cell proliferation stimulated by platelet-derived growth factor or endothelial cell growth factor
31. Reduced transplant arteriosclerosis in plasminogen-deficient mice
32. Sequential cytokine expression in renal allografts in rats immunosuppressed with maintenance cyclosporine or mycophenolate mofetil
33. Role of endogenous endothelin in the development of graft arteriosclerosis in rat cardiac allografts
34. Mechanisms of luminal narrowing in cardiac allograft vasculopathy: Inadequate vascular remodelling rather than intimal hyperplasia is the major predictor of coronary artery stenosis
35. Sustained anti-CD4/CD8 treatment blocks inflammatory activation and intimal thickening in mouse heart allografts
36. Heart transplants in interferon-γ interleukin 4, and interleukin 19 knockout mice
37. Inducible nitric oxide synthase expression in smooth muscle cells and macrophages of human transplant coronary artery disease
38. Inducible nitric oxide synthase expression in smooth muscle cells and macrophages of human transplant coronary artery disease
39. Conjugated estrogens acutely abolish abnormal cold-induced coronary vasoconstriction in male cardiac allografts
40. Coronary artery intimal thickening in the transplanted heart
41. Incidence and severity of transplant coronary artery disease early and up to 15 years after transplantation as detected by intravascular ultrasound
42. Prognostic importance of intimal thickness as measured by intracoronary ultrasound after cardiac transplantation
43. Chronic cardiac rejection in the LEW to F344 rat model
44. Coronary atherosclerosis in transplanted mouse hearts. IV. Effects of treatment with monoclonal antibodies to intercellular adhesion molecule-1 and leukocyte function-associated antigen-1
45. Rapamycin inhibits transplant vasculopathy in long-surviving rat heart allograft
46. A preliminary study of diltiazem in the prevention of coronary artery disease in heart-transplant recipients
47. Dichotomous pattern of coronary atherosclerosis 1 to 9 years after transplantation: Insights from systematic intravascular ultrasound imaging
48. Occult and frequent transmission of atherosclerosic coronary disease with cardiac transplantation
49. Cardiac events after heart transplantation: Incidence and predictive value of coronary arteriography
50. Plasma levels of tissue plasminogen activator and plasminogen activator inhibitor-1 are correlated with the presence of transplant coronary artery disease in cardiac transplant recipients
51. Up-regulation of endothelin-1 mRNA and peptide expression in rat cardiac allograft with rejection and arteriosclerosis
52. Coronary artery disease in the transplanted heart
53. Simvastatin reduces graft vessel disease and mortality after heart transplantation
54. Heterogeneity of coronary flow reserve in the examination of multiple individual allograft coronary arteries
55. Pharmacologically induced regression of chronic transplant rejection